Clinical Trial Update: Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD) [Phase 4]

View source ↗

Summary

This Phase 4 trial of amantadine for behavioral disturbance in Frontotemporal dementia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frontotemporal Dementia

Drugs mentioned

• amantadine (amantadine)

Snippet

Sponsor: Johns Hopkins University | Conditions: Dementia | Phase 4 | Status: WITHDRAWN